Paxmedica, Common Stock Stock Current Valuation
| PXMDDelisted Stock | USD 0.86 0.18 17.31% |
Valuation analysis of PaxMedica, Common Stock helps investors to measure PaxMedica, Common's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that PaxMedica, Common's price fluctuation is very steady at this time. Calculation of the real value of PaxMedica, Common Stock is based on 3 months time horizon. Increasing PaxMedica, Common's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PaxMedica, pink sheet is determined by what a typical buyer is willing to pay for full or partial control of PaxMedica, Common Stock. Since PaxMedica, Common is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PaxMedica, Pink Sheet. However, PaxMedica, Common's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.86 | Real 0.82 | Hype 0.86 | Naive 0.82 |
The real value of PaxMedica, Pink Sheet, also known as its intrinsic value, is the underlying worth of PaxMedica, Common Stock Company, which is reflected in its stock price. It is based on PaxMedica, Common's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of PaxMedica, Common's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of PaxMedica, Common Stock helps investors to forecast how PaxMedica, pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PaxMedica, Common more accurately as focusing exclusively on PaxMedica, Common's fundamentals will not take into account other important factors: PaxMedica, Common Stock Company Current Valuation Analysis
PaxMedica, Common's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current PaxMedica, Common Current Valuation | 388.33 K |
Most of PaxMedica, Common's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PaxMedica, Common Stock is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, PaxMedica, Common Stock has a Current Valuation of 388.33 K. This is 100.0% lower than that of the Biotechnology sector and 99.99% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
PaxMedica, Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PaxMedica, Common's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PaxMedica, Common could also be used in its relative valuation, which is a method of valuing PaxMedica, Common by comparing valuation metrics of similar companies.PaxMedica, Common is currently under evaluation in current valuation category among its peers.
PaxMedica, Fundamentals
| Return On Equity | -10.47 | ||||
| Return On Asset | -2.56 | ||||
| Current Valuation | 388.33 K | ||||
| Shares Outstanding | 7.47 M | ||||
| Shares Owned By Insiders | 8.14 % | ||||
| Shares Owned By Institutions | 1.60 % | ||||
| Number Of Shares Shorted | 637.72 K | ||||
| Price To Earning | 1.90 X | ||||
| Price To Book | 1.83 X | ||||
| EBITDA | (16.15 M) | ||||
| Net Income | (18.29 M) | ||||
| Cash And Equivalents | 9.06 K | ||||
| Total Debt | 173.54 K | ||||
| Debt To Equity | 0.07 % | ||||
| Book Value Per Share | 0.46 X | ||||
| Cash Flow From Operations | (10.77 M) | ||||
| Short Ratio | 0.10 X | ||||
| Earnings Per Share | (11.00) X | ||||
| Target Price | 3.0 | ||||
| Market Capitalization | 5.14 M | ||||
| Total Asset | 5.68 M | ||||
| Retained Earnings | (52.03 M) | ||||
| Working Capital | 3.89 M | ||||
| Net Asset | 5.68 M |
About PaxMedica, Common Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PaxMedica, Common Stock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PaxMedica, Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PaxMedica, Common Stock based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in PaxMedica, Pink Sheet
If you are still planning to invest in PaxMedica, Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PaxMedica, Common's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |